Diseases

For assessment of safety, it is necessary to measure the maximum possible force exerted by a bone conduction device coupled to the human head.

This preliminary report is an account of 21 consecutive patients who had tinnitus of the severe disabling type and were examined with quantitative electroencephalography (QEEG).

This study was conducted in an attempt to determine the efficacy of neurofeedback (NFB) in the treatment of patients suffering from vertigo or tinnitus. Results indicated that after NFB, power for delta and theta bands was reduced; however, an increase of power was noted for the alpha bands.

Audiograms and auditory evoked magnetic fields (AEFs) were observed in young male and female adults at different ages before and after being exposed to discotheque music for 4 hours. Sound pressure levels (SPLs) ranged from 95 dB (SPL) up to 130 dB (SPL).

Tinnitus as a symptom remains a serious multidisciplinary problem. Vertigo or dizziness is not noticed frequently in tinnitus patients, so vestibular function is not often studied.

All of 1,420 children seen for clarification of a hearing disorder or to follow up for known difficulty in hearing were questioned as to whether they experienced tinnitus. The interview was carried out after a hearing test was conducted, which was based on play audiometry or normal pure-tone threshold audiometry, depending on the age of […]

Cochlear implantation has been performed for 16 years by investigators at Semmelweis University. During this period, different types of cochlear implants have been used and, in 30% of cases, hearing was observed to be restored in the nonimplanted ear.

Transtympanic gentamicin administration has become a popular modality in the treatment of Ménière’s disease. This modality and other inner-ear medical therapy are gaining increased clinical and scientific attention.

In this report, we summarize our clinical experience with intratympanic dexamethasone treatment (IDT) for control of tinnitus.

Our goal was to attempt to establish neuropharmacological tinnitus control (i.e., relief) with medication directed to restoration of a deficiency in the g-aminobutyric acid – benzodiazepine – chloride receptor in tinnitus patients with a diagnosis of a predominantly central type tinnitus.